Company & Sponsor Intelligence
Kafrelsheikh University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting2
Completed1
Countries1
Therapeutic footprint
cerebral_palsystroke
Indexed studies
NCT06653946the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients
stroke · EgyptPHASE4
stroke · EgyptPHASE4
NCT06813599The Best Intervention to Improve Gait Pattern in Children with Spastic Diplegic Cerebral Palsy
cerebral_palsy · EgyptNA
cerebral_palsy · EgyptNA
NCT06120725Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke
stroke · EgyptPHASE3
stroke · EgyptPHASE3
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →